300+ investors in your industry, stage, and region Get
Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Financial Services
Photography
Cryptocurrency
Digital Media
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
Platforms
InsurTech
Construction
Mobile
Oil and Gas
Retail
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Medical Device
Wellness
Education
Sports
Legal
Automotive
eSports
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Theatre
Medical
Web3
Beauty
Recruiting
Celebrity
Cannabis
LGBT
Climate
Food and Beverage
Life Science
Publishing
Wine and Spirits
Fashion
Mobile Apps
Real Estate
Sporting Goods
Music
Art
Finance
Manufacturing
Infrastructure
FinTech
Social Media
Franchise
Internet
Mobile Advertising
Android
Impact
Proptech
Hardware
Transportation
Biotech
Social
Sustainability
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
LATAM
Egypt
United Kingdom
Oceania
Argentina
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Norway
Haiti
Sudan
Malawi
Isle of Man
Iran
Madagascar
Lesotho
Russian Federation
Turkey
Liberia
Nepal
Pakistan
Mexico
Tajikistan
Sweden
Zambia
Romania
Tunisia
Taiwan
Zimbabwe
Poland
Oman
Puerto Rico
Guernsey
Cameroon
Armenia
Colombia
China
Costa Rica
Côte d'Ivoire
Czech Republic
Marshall Islands
Kuwait
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Morocco
Australia
Jamaica
Sri Lanka
Guatemala
Switzerland
Kazakhstan
New Zealand
Cayman Islands
Venezuela
Myanmar
Uganda
Uruguay
Moldova
Botswana
Seychelles
Paraguay
France
South Africa
Denmark
Ghana
Georgia
Iraq
Philippines
Sierra Leone
El Salvador
Portugal
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Kenya
Latvia
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Dominican Republic
Asia
Bermuda
Spain
Albania
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Bahamas
Bahrain
Jersey
Estonia
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Grenada
Israel
Angola
Honduras
Lithuania
Cambodia
Iceland
Europe
Liechtenstein
Lebanon
Cyprus
Mongolia
Qatar
Slovenia
Peru
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Yellowstone Holding, VC Fund

Yellowstone Holding

VC Fund

Versoix, Switzerland

Yellowstone Holding is a VC fund in Versoix focused on Medical and Health Care. Yellowstone Holding promoting new innovative products or technologies from Switzerland to the Asia market via our strong connections.

Total investments:
8
Last investment:
Lead investor:
63%

Last updated:

Industries Yellowstone Holding invests in

MedicalHealth CareBiotechnologyManufacturingMedical Device

Stages Yellowstone Holding invests in

Series ASeries BSeedSeries CVenture - Series Unknown

Countries Yellowstone Holding invests in

SwitzerlandTaiwanGermanyPortugalUnited States

Round sizes

Series A $2.7M–$16MSeries B $4M–$11M

Round size

Series A
$2.7M–$16M
Series B
$4M–$11M

Investment Focus

Industry

  • Medical 5 (63%)
  • Health Care 3 (38%)
  • Biotechnology 3 (38%)
  • Manufacturing 3 (38%)
  • Medical Device 2 (25%)
See all 12 industries →

Stage

  • Series A 3 (38%)
  • Series B 2 (25%)
  • Seed 1 (13%)
  • Series C 1 (13%)
  • Venture - Series Unknown 1 (13%)

Country

  • Switzerland 4 (50%)
  • Taiwan 1 (13%)
  • Germany 1 (13%)
  • Portugal 1 (13%)
  • United States 1 (13%)

Investments

CompanyDescriptionRoundLinks
CryoTherapeutics is focusing on the development, demonstration of clinical benefit, and early-stage commercialization of a proprietary cryotherapy system for use in the treatment of coronary artery disease that causes heart attacks. The safety and efficacy of cryoenergy in the cardiovascular system has been demonstrated and CryoTherapeutics intendsto extend the benefits of cryoenergy to the problem of diseased coronary arteries. $10.8M / Series B / Apr 02, 2024
ZuriMED is an innovative team specialized in orthopedic biomechanics and biomaterials.They originated in and are currently based at the Laboratory for Orthopedic Biomechanics at the University Hospital Balgrist – one of the leading Orthopedic clinics in Switzerland.The ZuriMED team has been inventing and developing orthopedic implants since2009. They have developed, rigorously tested, and patented three fully featured devices (BTB Conversion Kit™, EndoCLIP™, ZuriACL™). $16.2M / Series A / Jul 04, 2023
NU-RISE LDA helping doctors provide better cancer treatment. They have developed a probe that goes inside the body. This probe will monitor, in real-time, the level of radiation the patient is receiving. The Doctor can target the cancer but avoid the healthy organs. Better, safer and more accurate radiation - it's an evolution for cancertreatment. $3.5M / Seed / Mar 04, 2023
Medyria is a Swiss medtech startup that engineers technologies for cardiovascular catheter navigation and sensing. They develop a unique guiding and sensing medical device based on proprietary Blood Flow Velocity Sensor technology. The TrackCath System is designed to be cost-effective and safe during EVAR procedures.Medyria's goal is todevelop devices that enable safer and more effective endovascular procedures. It was founded in 2014 and is based in Winterthur, Zurich, Switzerland. $4M / Series B / Jan 10, 2023
Hycom develops, manufactures, and sells implantable medical devices. $4.5M / Venture - Series Unknown / Mar 02, 2022
Calciscon is a Swiss diagnostic company. Calciscon's aim is to become the leading company for the assessment, prevention and treatment of biomineralization-related medical problems. $2.7M / Series A / Apr 14, 2021
Founded in November 2013, HuKui Bio provides total solution and value-added services to global medical devices customers. By focusing on medical electronics and handheld devices for digital healthcare and telemedicine, we do the designing and development in Taiwan, manufacturing in Asia, and delivering our sales & services globally. Combiningseasoned experts and investors from biomedical, tech, and financial industries, we strive to be the best partner in the Asia-Pacific region for MedTech developers, startups and corporates by completing projects on-time, on-budget and by meeting global quality standards concurrently. Our US company, HuKui Tech, is a subsidiary based in the Bay area, 100% owned by HuKui Bio since 2020. $5.5M / Series C / Jan 12, 2021
CUTISS AG can now bio-engineer large quantities of individually customized human skin grafts, denovoSkin™, starting off from a very small piece of healthy patient’s skin. Because of its intrinsic characteristics, denovoSkin™ is expected to result in a minimally scarring outcome after transplantation. denovoSkin™ received a Swissmedic, EMA and FDAOrphan drug designation for the treatment of burns. $7.3M / Series A / Jun 26, 2018

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Financial Services
Photography
Cryptocurrency
Digital Media
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
Platforms
InsurTech
Construction
Mobile
Oil and Gas
Retail
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Medical Device
Wellness
Education
Sports
Legal
Automotive
eSports
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Theatre
Medical
Web3
Beauty
Recruiting
Celebrity
Cannabis
LGBT
Climate
Food and Beverage
Life Science
Publishing
Wine and Spirits
Fashion
Mobile Apps
Real Estate
Sporting Goods
Music
Art
Finance
Manufacturing
Infrastructure
FinTech
Social Media
Franchise
Internet
Mobile Advertising
Android
Impact
Proptech
Hardware
Transportation
Biotech
Social
Sustainability
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
LATAM
Egypt
United Kingdom
Oceania
Argentina
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Norway
Haiti
Sudan
Malawi
Isle of Man
Iran
Madagascar
Lesotho
Russian Federation
Turkey
Liberia
Nepal
Pakistan
Mexico
Tajikistan
Sweden
Zambia
Romania
Tunisia
Taiwan
Zimbabwe
Poland
Oman
Puerto Rico
Guernsey
Cameroon
Armenia
Colombia
China
Costa Rica
Côte d'Ivoire
Czech Republic
Marshall Islands
Kuwait
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Morocco
Australia
Jamaica
Sri Lanka
Guatemala
Switzerland
Kazakhstan
New Zealand
Cayman Islands
Venezuela
Myanmar
Uganda
Uruguay
Moldova
Botswana
Seychelles
Paraguay
France
South Africa
Denmark
Ghana
Georgia
Iraq
Philippines
Sierra Leone
El Salvador
Portugal
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Kenya
Latvia
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Dominican Republic
Asia
Bermuda
Spain
Albania
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Bahamas
Bahrain
Jersey
Estonia
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Grenada
Israel
Angola
Honduras
Lithuania
Cambodia
Iceland
Europe
Liechtenstein
Lebanon
Cyprus
Mongolia
Qatar
Slovenia
Peru
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Yellowstone Holding invest in?

Yellowstone Holding invests primarily in Medical, Health Care and Biotechnology startups, most often at Series A and Series B stage. Most of the 8 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What round sizes does Yellowstone Holding invest in?

Yellowstone Holding typically joins rounds of $2.7M–$16M at Series A and $4M–$11M at Series B. These are whole funding-round sizes, not Yellowstone Holding's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Yellowstone Holding took part in.

When did Yellowstone Holding last invest?

The most recent investment recorded for Yellowstone Holding closed in Apr 2024. Shizune tracks 8 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Nov 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Yellowstone Holding Yellowstone Holding Find emails